The estimation of IL-2 and IL-2 receptors in peritoneal fluid of infertile patients with endometriosis
Observational
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Infertile endometriosis patients showed significantly higher peritoneal fluid IL-2 concentrations compared to controls, with higher CD25 expression on T cells in later disease stages.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: The aim of the study was to investigate the concentrations of interleukin-2 (IL-2), soluble interleukin-2 receptors (sIL-2R) and the expressions of CD25 antigen (IL-2Rα) on T CD3 + lymphocytes in peritoneal fluid of infertile patients with endometrisis in comparison with the reference group of patients with benign ovarian tumors. Material and Methods: Twenty four infertile patients with endometriosis and 18 patients from reference group were included in the study. The concentrations of IL-2 and soluble IL-2 receptors were measured with the use of ELISA immunoenzymatic method. The expressions of surface molecules were estimated using the two-color flow cytometric method. Results: The concentrations of IL-2 in peritoneal fluid of infertile patients with endometriosis were significantly higher when compared to the reference group (2.83±2.6 pg/ml vs. 1.27±1.58 pg/ml; p<0.05). The concentrations of soluble IL-2 receptors and the expressions of CD25 antigen on T CD3 + lymphocytes in the study group did not differ significantly when compared to the reference group (sIL-2R: 463.9±200.4 U/ml vs. 461.35±209.7 U/ml; NS; T CD3 + CD25 + : 6.77±8.18% vs. 5.7±6.43%; NS). However, we have found significant differences in immunological parameters between individual stages of endometriosis. The expressions of CD25 antigen were significantly higher in the second and third stages of endometriosis when compared to the first stage of the disease. Conclusions: The excessive concentrations of IL-2 in peritoneal fluid of patients with endometriosis may be responsible for an infertilty in these group of patients. Higher expressions of CD25 antigen on T CD3 + lymphocytes which are observed in the third and second stage of endometriosis can suggest the acivation of T CD3 + cells during the progression of the disease.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (12)
- [Alteration of peritoneal lymphocyte transformation and its interleukin-2 release in patients with infertility and endometriosis] via openalex
- A Study of Peritoneal Immunocompetent Cells in External Genital Endometriosis via openalex
- [Endometriosis and discouragement of immunology cytotoxic characteristics] via openalex
- IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis via openalex
- Lymphokine-activated killer activity in women with endometriosis via openalex
- Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells via openalex
- Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis via openalex
- The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis via openalex
- The role of cytokines in endometriosis via openalex
- Three-year follow-up of [CA-125, CA 19-9, CA 15-3, SIL-2R, IL-6, IL-la, TNF-a, sCD8 and sCD4] levels in a woman with severe endometriosis via openalex
- W2105906741 via openalex
- W2028712686 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK